These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31192427)

  • 1. [Subsidized TBE vaccination appears cost-effective in a life-time perspective].
    Askling H; Shedrawy J; Henriksson M
    Lakartidningen; 2019 Jun; 116():. PubMed ID: 31192427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating costs and health outcomes of publicly funded tick-born encephalitis vaccination: A cost-effectiveness analysis.
    Shedrawy J; Henriksson M; Hergens MP; Askling HH
    Vaccine; 2018 Nov; 36(50):7659-7665. PubMed ID: 30385058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccines for tick-borne diseases and cost-effectiveness of vaccination: a public health challenge to reduce the diseases' burden.
    Šmit R; Postma MJ
    Expert Rev Vaccines; 2016; 15(1):5-7. PubMed ID: 26559456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of tick-borne encephalitis vaccination in Slovenian adults.
    Smit R
    Vaccine; 2012 Sep; 30(44):6301-6. PubMed ID: 22885012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of a potential anti-tick vaccine with combined protection against Lyme borreliosis and tick-borne encephalitis in Slovenia.
    Mihajlović J; Hovius JWR; Sprong H; Bogovič P; Postma MJ; Strle F
    Ticks Tick Borne Dis; 2019 Jan; 10(1):63-71. PubMed ID: 30197268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Willingness to Pay for Vaccination against Tick-Borne Encephalitis and Implications for Public Health Policy: Evidence from Sweden.
    Slunge D
    PLoS One; 2015; 10(12):e0143875. PubMed ID: 26641491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-benefit analysis of vaccination against tick-borne encephalitis among French troops.
    Desjeux G; Galoisy-Guibal L; Colin C
    Pharmacoeconomics; 2005; 23(9):913-26. PubMed ID: 16153134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Health economics of early summer meningoencephalitis in Austria. Effects of a vaccination campaign 1981 to 1990].
    Schwarz B
    Wien Med Wochenschr; 1993; 143(21):551-5. PubMed ID: 8147001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of tick-borne encephalitis and vaccines: clinical and economical aspects.
    Šmit R; Postma MJ
    Expert Rev Vaccines; 2015 May; 14(5):737-47. PubMed ID: 25427237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported tick-borne encephalitis (TBE) vaccination coverage in Europe: Results from a cross-sectional study.
    Erber W; Schmitt HJ
    Ticks Tick Borne Dis; 2018 May; 9(4):768-777. PubMed ID: 29501619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost-benefit ratio of tick-borne encephalitis vaccination of French troops based in Kosovo].
    Desjeux G; Lemardeley P; Colin C; Pascal B; Labarère J
    Rev Epidemiol Sante Publique; 2001 Jun; 49(3):249-57. PubMed ID: 11427828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tick-borne encephalitis vaccination in Sweden is not self-evident].
    Fagrell B; Bergstrand G
    Lakartidningen; 2017 May; 114():. PubMed ID: 28485761
    [No Abstract]   [Full Text] [Related]  

  • 13. Tick borne encephalitis (TBE)-vaccination coverage and analysis of variables associated with vaccination, Sweden.
    Askling HH; Insulander M; Hergens MP; Leval A
    Vaccine; 2015 Sep; 33(38):4962-8. PubMed ID: 26207593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reviewing estimates of the burden in disability-adjusted life years (DALYs) of tick-borne encephalitis in Slovenia.
    Šmit R
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):299-303. PubMed ID: 30686078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
    Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
    Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of sex-neutral HPV-vaccination in Sweden, accounting for herd-immunity and sexual behaviour.
    Wolff E; Elfström KM; Haugen Cange H; Larsson S; Englund H; Sparén P; Roth A
    Vaccine; 2018 Aug; 36(34):5160-5165. PubMed ID: 30017146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tick-borne encephalitis in children in Styria and Slovenia between 1980 and 2003.
    Zenz W; Pansi H; Zoehrer B; Mutz I; Holzmann H; Kraigher A; Berghold A; Spork D
    Pediatr Infect Dis J; 2005 Oct; 24(10):892-6. PubMed ID: 16220087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of a routine varicella vaccination program for US children.
    Lieu TA; Cochi SL; Black SB; Halloran ME; Shinefield HR; Holmes SJ; Wharton M; Washington AE
    JAMA; 1994 Feb; 271(5):375-81. PubMed ID: 8283587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TBE vaccination and the Austrian experience.
    Kunz C
    Vaccine; 2003 Apr; 21 Suppl 1():S50-5. PubMed ID: 12628814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.
    Wittermann C; Petri E; Zent O
    Vaccine; 2009 Mar; 27(10):1585-8. PubMed ID: 19162115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.